VILAFINIL 300

What is VILAFINIL 300?

VILAFINIL 300 is a modern medicinal product from the group of nootropics and analeptics, designed for targeted support of central nervous system functions. The product is developed by the Indian pharmaceutical company Fortune Healthcare, which specializes in the manufacture of high-quality generics in compliance with international GMP standards. The drug is available in the form of tablets for oral use with a fixed dose of the active substance, which ensures convenient dosing and control of administration. The main task of VILAFINIL 300 is to improve alertness, concentration, and cognitive endurance in states of increased sleepiness. The pharmacological group of the agent includes indirect-acting stimulants that gently activate certain neurotransmitter systems without a pronounced effect on peripheral hemodynamics.

The mechanism of action of VILAFINIL 300 is based on the modulation of the activity of the hypothalamus and other brain structures responsible for the sleep-wake cycle. The drug promotes an increase in dopamine levels in the synaptic cleft by blocking its reuptake, and also indirectly affects noradrenergic and histaminergic transmission. Fortune Healthcare ensures stable bioavailability and a predictable pharmacokinetic profile, which is important for long-term therapy under the supervision of a specialist. Clinical use of the agent is targeted at patients who need support for mental performance and reduction of daytime sleepiness. Before starting the course, a consultation with a doctor is mandatory, as the body's response to VILAFINIL 300 is individual.

The package usually contains instructions with a detailed description of properties, indications, and precautions. VILAFINIL 300 is positioned as an auxiliary tool in the complex correction of alertness disorders, rather than a universal "energy booster" for self-treatment. The manufacturer emphasizes the quality of raw materials and control of each production batch. Storage and transportation are carried out taking into account the requirements for medicines sensitive to moisture and temperature. Any decision regarding administration must be based on an assessment of the patient's health status by a qualified specialist.

What is VILAFINIL 300 prescribed for?

The main indication for the use of VILAFINIL 300 is excessive daytime sleepiness associated with narcolepsy, when a person experiences sudden daytime sleep attacks. The drug helps maintain a stable level of alertness during the working day and reduces the frequency of involuntary sleep episodes. Doctors also consider it for obstructive sleep apnea syndrome as an adjunct to primary therapy after night-time breathing has normalized. In such cases, VILAFINIL 300 helps improve daytime activity and the ability to concentrate. The prescription is always individual and depends on the results of the medical examination.

Another area of use is sleep-wake cycle disorders in people with shift work schedules, particularly when working night shifts. The product allows adjusting circadian rhythms and reducing the feeling of exhaustion after a night shift. VILAFINIL 300 can be used in a comprehensive approach for asthenic states accompanied by a decline in cognitive functions and rapid fatigability. It is important to understand that the drug does not replace healthy sleep and is not intended for chronic "boosting" without medical grounds. The decision on therapy is made by a doctor after assessing the benefits and risks.

In certain clinical situations, specialists consider VILAFINIL 300 as part of support in states where sustained attention and reaction speed are critical. The drug is not a first-line treatment for depression or anxiety disorders, although it is sometimes used as an adjuvant under strict supervision. Patients should inform their doctor about all concomitant diseases and already prescribed medications. Independent expansion of indications or dose increases are unacceptable. The individual response of the body can vary significantly, so regular monitoring of the condition is mandatory.

Composition and active components of VILAFINIL 300

The main active ingredient of VILAFINIL 300 is modafinil at a dosage of three hundred milligrams per tablet. Modafinil belongs to the group of eugeroics and helps maintain alertness by affecting the neurotransmitter systems of the brain. The substance blocks the reuptake of dopamine, increasing its availability in the synapses, and also modulates the activity of orexin neurons. Thanks to this, a wakefulness effect is achieved without the "hyperactivity" typical of classic psychostimulants. Fortune Healthcare uses a substance of pharmaceutical purity that meets international requirements.

Excipients of the tablet ensure shape stability, solubility, and ease of swallowing. Among them are usually microcrystalline cellulose, lactose or its substitutes, starch, magnesium stearate, and a film coating. These substances do not have an independent pharmacological effect, but they influence the release rate of the active substance. Patients with intolerance to lactose or individual fillers should carefully study the composition and consult a doctor. The mechanism of action of VILAFINIL 300 is central, so systemic effects on the cardiovascular system are less pronounced compared to amphetamine-like agents, but blood pressure monitoring remains important.

The pharmacokinetics are characterized by a sufficiently long half-life, which allows maintaining the effect for most of the day with a single dose. Metabolism occurs mainly in the liver with the participation of cytochrome P450, so the state of liver enzymes affects the concentration of the drug in the blood. Elimination of metabolites is carried out by the kidneys, which requires caution in case of impaired renal function. Understanding the composition helps to predict possible interactions and select the optimal regimen. Any changes in the composition or the appearance of a new batch do not eliminate the need for medical supervision.

Dosage of VILAFINIL 300

The standard recommended dose of VILAFINIL 300 for adult patients is one tablet per day, which corresponds to three hundred milligrams of modafinil. Administration is usually carried out in the morning to maximize daytime alertness and minimize the risk of nighttime sleep disturbance. In some clinical cases, a doctor may start therapy with a lower dose, followed by an increase depending on the body's response and tolerability. The duration of the course is determined individually and can range from a few weeks to a longer period under regular supervision. An independent increase in the dose beyond the prescribed amount is strictly prohibited.

Dose adjustment is required for elderly patients, individuals with liver or kidney function disorders, as well as with the simultaneous use of drugs that affect the metabolism of modafinil. In case of severe hepatic insufficiency, the daily amount is often halved or an alternative regimen is selected. For patients with shift schedules, the time of administration may be shifted to match the start of the work shift, but only upon the recommendation of a specialist. Regular assessment of effectiveness and side effects allows for timely adjustments to therapy. VILAFINIL 300 is not intended for continuous use over many years without periodic review of indications.

The maximum daily dose should not exceed the value specified in the official instructions and confirmed by a doctor. In the absence of the expected effect within a reasonable timeframe, the therapy is reviewed rather than increasing the dose independently. It is important to record the time of administration and subjective feelings in a diary so that the doctor can objectively assess the dynamics. An individual reaction of the body may require complete discontinuation of the agent even with a formally "correct" dosage. Before any change in the regimen, an in-person or remote consultation with a doctor is required.

How to take VILAFINIL 300 correctly?

The VILAFINIL 300 tablet is swallowed whole with a sufficient amount of clean, still water. It is advisable to take it on an empty stomach or with a light breakfast, avoiding fatty foods, which can somewhat delay absorption. The optimal time is immediately after waking up or one hour before starting active work that requires increased attention. It is not recommended to break or chew the tablet unless the instructions directly provide for splitting. Adherence to a consistent administration regimen improves the predictability of the drug's action.

In case of a missed dose, the next tablet is taken at the usual time the next day, without doubling the amount. An attempt to "catch up" on a missed dose increases the risk of side effects and sleep disturbances. During the course, one should avoid sudden changes in the daily routine and ensure a sufficient duration of night rest. Patients should refrain from additional use of other stimulants without consulting a doctor. The warning also applies to the abrupt discontinuation of long-term use: withdrawal should preferably be carried out under the supervision of a specialist.

Before starting use, it is necessary to carefully read the instructions and discuss all concomitant conditions with a doctor. VILAFINIL 300 does not replace sleep hygiene, lifestyle adjustment, or treatment of the underlying disease causing sleepiness. Store the drug out of reach of children and do not pass it on to other persons even with similar complaints. If unusual symptoms appear, the administration is stopped, and medical help is sought immediately. The individual response of the body may include both expected and atypical manifestations, so self-monitoring is an important element of safety.

Side effects of VILAFINIL 300

Among the frequent side effects of VILAFINIL 300 are headache, nausea, dry mouth, nervousness, and decreased appetite. Some patients report insomnia, especially if the tablet is taken too late in the day. Dizziness, feelings of anxiety, and a moderate increase in blood pressure are also possible. Most of these events are dose-dependent and decrease with regimen adjustment or body adaptation. For persistent or worsening symptoms, consultation with a doctor is required.

Infrequent reactions include skin rashes, itching, chest pain, rapid heartbeat, and changes in laboratory parameters of liver enzymes. Rare but serious complications include severe allergic reactions, Stevens-Johnson syndrome, and other forms of toxic epidermal necrolysis. Mental changes in the form of agitation, aggression, or the appearance of suicidal thoughts require immediate discontinuation of use and seeking help. Patients with pre-existing mental disorders require particularly careful monitoring. Any new or unexplained symptom should be considered as a reason to contact a doctor.

If shortness of breath, swelling of the face, difficulty swallowing, or a sharp drop in blood pressure occur, emergency help must be called. Monitoring of blood pressure and heart rate at the beginning of therapy helps to detect unwanted cardiac effects in a timely manner. Women of reproductive age should consider the possible impact on the effectiveness of hormonal contraceptives and discuss additional protection methods. The individual response of the body to VILAFINIL 300 can manifest even at minimal doses, so "test" administration without supervision is unacceptable. Regular visits to the doctor minimize risks and allow for treatment adjustment.

Contraindications of VILAFINIL 300

Absolute contraindications to the use of VILAFINIL 300 are hypersensitivity to modafinil or any component of the tablet, as well as severe uncontrolled cardiovascular conditions. The drug is not prescribed for acute rhythm disorders, unstable angina, and recent myocardial infarction without stabilization. Childhood and adolescence are usually a restriction, as safety and efficacy in this group have not been sufficiently studied. Pregnancy and lactation are conditions where the benefits must be clearly weighed against the potential risk to the fetus or child. An independent decision to take the drug in these situations is unacceptable.

Relative contraindications include arterial hypertension, moderate to severe liver disease, impaired renal function, and a history of psychotic episodes. Elderly patients require dose reduction and more frequent monitoring due to possible slowing of metabolism. Individuals with a history of substance abuse have an increased risk of abuse, so the prescription is made with extreme caution. Before starting the course, the doctor evaluates the electrocardiogram, blood pressure, and baseline laboratory parameters. VILAFINIL 300 is not recommended for "preventive" use by healthy people to increase productivity.

Women planning a pregnancy should discuss the timing of drug discontinuation in advance. During lactation, the issue of continuing therapy is decided individually, taking into account the possibility of the active substance passing into breast milk. Any allergic reactions to similar stimulants in the past are a strong argument against prescription. The individual response of the body may reveal hidden contraindications after the first doses, so the starting period requires increased attention. Consultation with a doctor before taking VILAFINIL 300 is a mandatory condition for safe use.

Interaction of VILAFINIL 300 with other drugs and alcohol

VILAFINIL 300 affects the activity of cytochrome P450 enzymes, in particular, it induces CYP3A4 and can reduce the effectiveness of hormonal contraceptives, cyclosporine, certain statins, and anticonvulsants. Co-administration with inhibitors or inducers of these enzymes changes the concentration of modafinil in the blood and requires dose adjustment. Combination with other central nervous system stimulants increases the risk of tachycardia, hypertension, and nervous excitement. Antidepressants, especially from the group of selective serotonin reuptake inhibitors, can increase anxiety or insomnia. A complete list of medications taken by the patient must be provided to the doctor before starting therapy.

Alcohol is not recommended during the use of VILAFINIL 300, as ethanol increases the load on the liver and can mask or distort the effect of the drug. The combination can impair coordination, attention, and reaction time, which is especially dangerous when driving. On its own, VILAFINIL 300 can affect the ability to drive vehicles and use complex machinery, especially at the beginning of the course, until the individual response is determined. Patients are advised to refrain from driving until they are confident in the absence of dizziness or excessive excitement. Any doubts regarding compatibility with other agents or alcohol are resolved only after consultation with a doctor.

Where to buy VILAFINIL 300 in Ukraine

VILAFINIL 300 can be found in pharmacy chains in Ukraine, as well as ordered through licensed online pharmacies with a prescription, if required by current legislation. Before purchasing, it is worth checking the availability of quality certificates and the integrity of the package to avoid counterfeits. Storage conditions require a dry place at room temperature, protected from direct sunlight and out of reach of children. Delivery is usually carried out in thermal bags or standard pharmacy containers in compliance with the temperature regime. The final decision on purchase and use is made only after consultation with a doctor, taking into account the individual response of the body and current indications.